Specifying Control Over Ion Balance and Glucose Homeostasis Through mTORC2

通过 mTORC2 指定对离子平衡和葡萄糖稳态的控制

基本信息

项目摘要

DESCRIPTION (provided by applicant): The overall goal of this research proposal is to further elucidate the molecular mechanisms that underlie mTORC2 target specificity and their functional implications in the regulation of glucose homeostasis and ion balance, using biochemical, electrophysiological, metabolic, genetic and whole animal physiology techniques. The applicant for the K01 Mentored Career Development Award, Dr. Catherine E. Gleason, is currently a postdoctoral fellow in Dr. David Pearce's laboratory at UCSF. Dr. Gleason's long-term research goal is to study how metabolic signaling pathways intersect and influence pathways controlling various biological functions, notably ion balance by the kidney, for maintenance of physiological homeostasis. Dr. Gleason's long-term career goal is to establish an independent molecular physiology research program as a tenure-track investigator at an academic institution. SGK1 and Akt are highly related protein kinases that function as key mediators of the signaling pathways that control ion and metabolic homeostasis, respectively. Recently, mTORC2 was identified as the kinase responsible for activation of these kinases by phosphorylation of a critical, homologous residue in their hydrophobic motif (HM). Since, stimuli that induce mTORC2 activity, such as insulin and IGF1, trigger phosphorylation of both SGK1 and Akt, how mTORC2 is able to modulate activity of these related kinases in such a way that allows them to mediate distinct effects on electrolyte balance and energy metabolism is not understood. Notably, in addition to its well-established role in ion balance, the kidney also plays an important role in whole animal energy homeostasis due to its significant gluconeogenic capacity. It is unclear how the kidney is able to sort crosstalk from multiple signaling pathways to allow for appropriate, context-dependent regulation of its metabolic and ion balance functions. Thus, understanding the molecular dynamics surrounding mTORC2 selective activation of SGK1 and Akt, in vitro and in vivo, are open and important areas for investigation. Dr. Gleason will build on her background in metabolic physiology and signal transduction with additional training in the cellular and whole animal study of ion transport processes to address the mechanistic basis for mTORC2 specificity towards SGK1 vs. Akt and their functional implications at the cellular and whole animal levels through two specific aims: 1) Investigate the hormonal stimuli and/or cellular conditions that regulate mTORC2 specific activation of SGK1 vs. Akt. 2) Characterize the relative contributions of Akt and SGK1 towards renal glucose metabolism and ion balance in vivo. The training period provided by the K01 Mentored Career Development Award will provide Dr. Gleason with a comprehensive toolbox for her independent career investigating the intersections of metabolism with diverse signaling pathways in health and disease.
描述(由申请人提供):这项研究建议的总体目标是进一步阐明MTORC2靶向特异性的分子机制及其在调节葡萄糖稳态和离子平衡中的功能含义,并使用生物化学,电生理学,代谢,整个,遗传和整个,遗传和整个,遗传,遗传和整个,遗传,遗传,遗传和整个动物生理技术。 K01指导职业发展奖的申请人Catherine E. Gleason博士目前是UCSF David Pearce博士实验室的博士后研究员。格里森博士的长期研究目标是研究代谢信号通路如何相交和影响控制各种生物学功能的途径,特别是肾脏的离子平衡,以维持生理稳态。格里森博士的长期职业目标是建立一个独立的分子生理研究计划,成为学术机构的终身调查员。 SGK1和AKT是高度相关的蛋白激酶,可作为控制离子和代谢稳态的信号传导途径的关键介体。最近,通过在其疏水基序中的关键,同源残基的磷酸化(HM),MTORC2被鉴定为负责激活这些激酶的激酶。由于诱导MTORC2活性的刺激(例如胰岛素和IGF1)触发SGK1和AKT的磷酸化,MTORC2如何能够以这种方式调节这些相关激酶的活性,从而使它们能够介导对电解质平衡和能量平衡的不同影响不了解。值得注意的是,除了其在离子平衡中的良好作用外,肾脏还发挥了作用 由于其明显的糖原能力,在整个动物能量稳态中的重要作用。目前尚不清楚肾脏如何从多个信号通路中对串扰进行分类,以允许对其代谢和离子平衡功能进行适当的,依赖上下文的调节。因此,了解MTORC2选择性激活SGK1和AKT,体外和体内的分子动力学是开放且重要的研究领域。格里森博士将在其代谢生理学和信号转导的背景下建立在离子传输过程中的细胞和整个动物研究中的其他训练,以解决MTORC2特异性对SGK1的机械基础,而SGK1与AKT及其在细胞中的功能含义及其功能含义动物水平通过两个特定的目的:1)研究调节MTORC2特异性SGK1与AKT的激素刺激和/或细胞条件。 2)表征AKT和SGK1对体内肾葡萄糖代谢和离子平衡的相对贡献。 K01指导职业发展奖提供的培训期将为格里森博士提供全面的工具箱,以调查新陈代谢与健康和疾病中各种信号通路的交集。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Catherine Gleason其他文献

Catherine Gleason的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Catherine Gleason', 18)}}的其他基金

Specifying Control Over Ion Balance and Glucose Homeostasis Through mTORC2
通过 mTORC2 指定对离子平衡和葡萄糖稳态的控制
  • 批准号:
    8911307
  • 财政年份:
    2013
  • 资助金额:
    $ 14.78万
  • 项目类别:
Specifying Control Over Ion Balance and Glucose Homeostasis Through mTORC2
通过 mTORC2 指定对离子平衡和葡萄糖稳态的控制
  • 批准号:
    8735013
  • 财政年份:
    2013
  • 资助金额:
    $ 14.78万
  • 项目类别:
Specifying Control Over Ion Balance and Glucose Homeostasis Through mTORC2
通过 mTORC2 指定对离子平衡和葡萄糖稳态的控制
  • 批准号:
    9117514
  • 财政年份:
    2013
  • 资助金额:
    $ 14.78万
  • 项目类别:

相似国自然基金

PKCε-Rab11介导KCNQ1通道膜蛋白下调促进血管紧张素II诱导的心肌肥厚致心律失常的机制研究
  • 批准号:
    82204397
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
血管紧张素II活化的钙振荡在TBI后PSH相关的神经功能损害中的作用与机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
血管紧张素II2型受体在血管损伤中抑制周围脂肪组织功能失调的作用及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
LncRNA XIST通过micRNA-144-3p靶向Nrf2调控血管紧张素II引起心肌损伤的机制
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
血管紧张素II调控ATF3诱导铁死亡促进心梗后心室重构的机制研究
  • 批准号:
    82000249
  • 批准年份:
    2020
  • 资助金额:
    24 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
REVAMP-PH:重新利用缬沙坦可以预防肺动脉高压
  • 批准号:
    10642368
  • 财政年份:
    2023
  • 资助金额:
    $ 14.78万
  • 项目类别:
Endothelial Piezo1 channel and cerebral blood flow control
内皮Piezo1通道与脑血流控制
  • 批准号:
    10719633
  • 财政年份:
    2023
  • 资助金额:
    $ 14.78万
  • 项目类别:
Matricellular protein CCN3 in vascular homeostasis
基质细胞蛋白 CCN3 在血管稳态中的作用
  • 批准号:
    10504077
  • 财政年份:
    2022
  • 资助金额:
    $ 14.78万
  • 项目类别:
Matricellular protein CCN3 in vascular homeostasis
基质细胞蛋白 CCN3 在血管稳态中的作用
  • 批准号:
    10662518
  • 财政年份:
    2022
  • 资助金额:
    $ 14.78万
  • 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Role of Hypertension in Favoring Osteoporosis
BCCMA:针对和抵抗不利于骨骼的条件(骨折遏制)的基础研究:高血压在促进骨质疏松症中的作用
  • 批准号:
    10483572
  • 财政年份:
    2022
  • 资助金额:
    $ 14.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了